---
stable_id: R-HSA-1225950
display_name: Binding of GRB2:SOS1 complex to phosphorylated ligand-responsive EGFR
  mutants
species: Homo sapiens
summary: 'Direct binding of GRB2:SOS1 complex to phosphorylated homodimers of EGFR
  cancer mutants has not been tested. GRB2 binds to phosphorylated tyrosine residues
  Y1068 and Y1086 (corresponding to Y1092 and Y1110, respectively, when counting from
  the first amino acid of the EGFR precursor, prior to cleavage of the 24-amino acid
  signal peptide at the N-terminus). Phosphorylation of Y1068 (i.e. Y1092) has been
  directly demonstrated in the following EGFR cancer mutants: EGFR L858R mutant (Sordella
  et al. 2004, Lynch et al. 2004, Greulich et al. 2005, Yang et al. 2006, Choi et
  al. 2007); EGFR G719S mutant (Greulich et al. 2005, Choi et al. 2007); EGFR L747_P753insS
  mutant (Sordella et al. 2004, Lynch et al. 2004, Choi et al. 2007); EGFR L747_A750delinsP
  (Greulich et al. 2005); EGFR L747_S752del mutant (Pao et al. 2004); EGFR L861Q mutant
  (Lee et al. 2006, Yang et al. 2006); EGFRvIII mutant (Huang et al. 2007); EGFR A289V
  mutant (Lee et al. 2006); EGFR G598V mutant (Lee et al. 2006); EGFR R108K mutant
  (Lee et al. 2006); EGFR T263P mutant (Lee et al. 2006); EGFR D770_N771insNPG mutant
  (Greulich et al. 2005, Xu et al. 2007); EGFR N771_H773dup mutant (Xu et al. 2007);
  EGFR K739_I744dup mutant (Xu et al. 2007); EGFR A767_V769dup mutant (Xu et al. 2007).'
---

# Binding of GRB2:SOS1 complex to phosphorylated ligand-responsive EGFR mutants
**Reactome ID:** [R-HSA-1225950](https://reactome.org/content/detail/R-HSA-1225950)
**Species:** Homo sapiens

## Summary

Direct binding of GRB2:SOS1 complex to phosphorylated homodimers of EGFR cancer mutants has not been tested. GRB2 binds to phosphorylated tyrosine residues Y1068 and Y1086 (corresponding to Y1092 and Y1110, respectively, when counting from the first amino acid of the EGFR precursor, prior to cleavage of the 24-amino acid signal peptide at the N-terminus). Phosphorylation of Y1068 (i.e. Y1092) has been directly demonstrated in the following EGFR cancer mutants: EGFR L858R mutant (Sordella et al. 2004, Lynch et al. 2004, Greulich et al. 2005, Yang et al. 2006, Choi et al. 2007); EGFR G719S mutant (Greulich et al. 2005, Choi et al. 2007); EGFR L747_P753insS mutant (Sordella et al. 2004, Lynch et al. 2004, Choi et al. 2007); EGFR L747_A750delinsP (Greulich et al. 2005); EGFR L747_S752del mutant (Pao et al. 2004); EGFR L861Q mutant (Lee et al. 2006, Yang et al. 2006); EGFRvIII mutant (Huang et al. 2007); EGFR A289V mutant (Lee et al. 2006); EGFR G598V mutant (Lee et al. 2006); EGFR R108K mutant (Lee et al. 2006); EGFR T263P mutant (Lee et al. 2006); EGFR D770_N771insNPG mutant (Greulich et al. 2005, Xu et al. 2007); EGFR N771_H773dup mutant (Xu et al. 2007); EGFR K739_I744dup mutant (Xu et al. 2007); EGFR A767_V769dup mutant (Xu et al. 2007).
